aslan pharmaceuticals press release
「aslan pharmaceuticals press release」熱門搜尋資訊
![aslan pharmaceuticals press release](https://i0.wp.com/api.multiavatar.com/aslan+pharmaceuticals+press+release.png?apikey=viVnb6N20jclO8)
「aslan pharmaceuticals press release」文章包含有:「ASLANPharmaceuticalsAnnouncesPublicationinClinical」、「ASLANPharmaceuticalsLimited」、「ASLANPharmaceuticalsLimited(ASLN)LatestPress...」、「ASLANPharmaceuticalsReportsFirstQuarter2023...」、「ASLANPharmaceuticalsReportsSecondQuarter2023...」、「ASLANPharmaceuticals」、「News&Publications」、「PRESSRELEASE」、「PressReleaseArchives」
查看更多![ASLAN Pharmaceuticals Announces Publication in Clinical](https://api.multiavatar.com/ASLAN+Pharmaceuticals+Announces+Publication+in+Clinical.png?apikey=viVnb6N20jclO8)
ASLAN Pharmaceuticals Announces Publication in Clinical
https://www.globenewswire.com
ASLAN Pharmaceuticals Announces Publication in Clinical Immunology Highlighting Eblasakimab's Unique Mechanism of Action in the Treatment of ...
![ASLAN Pharmaceuticals Limited](https://api.multiavatar.com/ASLAN+Pharmaceuticals+Limited.png?apikey=viVnb6N20jclO8)
ASLAN Pharmaceuticals Limited
https://www.globenewswire.com
ASLAN Pharmaceuticals to Host Webcast on July 6, 2023, to Discuss Phase 2b Topline Data From TREK-AD Trial Evaluating Eblasakimab in Atopic Dermatitis.
![ASLAN Pharmaceuticals Limited (ASLN) Latest Press ...](https://api.multiavatar.com/ASLAN+Pharmaceuticals+Limited+%28ASLN%29+Latest+Press+....png?apikey=viVnb6N20jclO8)
ASLAN Pharmaceuticals Limited (ASLN) Latest Press ...
https://finance.yahoo.com
ASLAN Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update · Eblasakimab Monthly Dosing Shows Potential for Best-In-Class ...
![ASLAN Pharmaceuticals Reports First Quarter 2023 ...](https://api.multiavatar.com/ASLAN+Pharmaceuticals+Reports+First+Quarter+2023+....png?apikey=viVnb6N20jclO8)
ASLAN Pharmaceuticals Reports First Quarter 2023 ...
https://aslanpharma.com
... the first quarter ended March 31, 2023, and provided an update on recent corporate activities. For more information, please refer to the press release.
![ASLAN Pharmaceuticals Reports Second Quarter 2023 ...](https://api.multiavatar.com/ASLAN+Pharmaceuticals+Reports+Second+Quarter+2023+....png?apikey=viVnb6N20jclO8)
ASLAN Pharmaceuticals Reports Second Quarter 2023 ...
https://aslanpharma.com
ASLAN Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update ... Please refer to the press release in full.
![ASLAN Pharmaceuticals](https://api.multiavatar.com/ASLAN+Pharmaceuticals%3A+About+ASLAN.png?apikey=viVnb6N20jclO8)
ASLAN Pharmaceuticals
https://ir.aslanpharma.com
ASLAN Pharmaceuticals is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients.
![News & Publications](https://api.multiavatar.com/News+%26amp%3B+Publications.png?apikey=viVnb6N20jclO8)
News & Publications
https://aslanpharma.com
Read about our latest product developments and partnerships, industry advances and events. News. 11 Aug 2023. ASLAN Pharmaceuticals Reports Second Quarter 2023 ...
![PRESS RELEASE](https://api.multiavatar.com/PRESS+RELEASE.png?apikey=viVnb6N20jclO8)
PRESS RELEASE
https://aslanpharma.com
PRESS RELEASE. ASLAN PHARMACEUTICALS ... San Mateo, California, and Singapore, March 24, 2023 – ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage,.
![Press Release Archives](https://api.multiavatar.com/Press+Release+Archives+-+ASLAN+Pharmaceuticals.png?apikey=viVnb6N20jclO8)
Press Release Archives
https://aslanpharma.com
San Mateo, California, and Singapore, June 1, 2023 – ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical company ...